Key facts
- Bot MD’s last known valuation is $1.7M (Aug 2018).
- It has raised $7.4M; the latest was Later Stage VC in Sep 2025.
- Notable investors include Y Combinator, SGInnovate, Monk's Hill Ventures, Grant Park Ventures, Verge Capital Management — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Bot MD
- ·The full record, as it builds
Funding rounds
No funding rounds for Bot MD are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bot MD
Developer of an artificial intelligence-based clinical assistance platform intended to help automate appointment scheduling, reminders, and remote monitoring. The company's platform automates multilingual patient interactions across popular chat apps, integrates with existing hospital information systems and EMR/CMS for real time scheduling and reminders, supports remote monitoring of vital signs with automated alerts and medication guidance, enables pre-admission intake and patient education modules, and provides clinical staff with dashboards for triaging, compliance tracking and analytics, enabling hospitals and clinics to streamline operations, improve patient adherence, support overworked care teams, and drive better health outcomes.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2018
- Employees
- 32
- Website
- botmd.io/
- Ownership
- Privately Held (backing)
Bot MD doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bot MD shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bot MD in its N-PORT filings yet. We sweep new filings monthly.